Company Overview and News
By acquiring Lonmin (OTC:LNMIF) Sibanye (SBGL) aims to become Nr. 2 platinum miner in the world. When the deal was announced on December 14, 2017, Lonmin shares went 20% up. SBGL, 4.6% down. Despite the ambitions, both companies are currently facing many problems on their own:
HHRBF S LNMIF
19h zacks - 1
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), EOG Resources (EOG) and Simon Property Group (SPG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP TXN NFLX MS WFC UNP EOG S SPG
Kimco Realty Corp. (KIM - Free Report) is making every effort to add value to its properties. Recently, the company announced the opening of the 32,000-square-foot store of the natural food grocer — Sprouts Farmers Market, Inc. (SFM - Free Report) — at its iconic mixed-use development, Lincoln Square, at Philadelphia’s Center City District. This marks Sprouts Farmers Market's foray into Pennsylvania.
TGT SFM S SBUX LB KIM
SAO PAULO, Sept 19 (Reuters) - Telefonica Brasil SA has signed a partnership deal with music streaming app Tidal, Brazil’s largest telecoms firm said on Wednesday as it continues to expand its content offerings.
Yesterday, President Donald Trump announced a new round of tariffs on Chinese goods — $200 billion to be exact. In response, China issued a $60 billion levy on U.S. goods. In an increasingly global economy, prospects for a trade war with China tend to foster nervousness among investors.
DLTR X S T TMUS DG VZ SAVE STZ CGC LUV
2018-09-17 zacks - 1
Sprint Corporation (S - Free Report) recently introduced a protection plan, Sprint Complete. The company’s new protection plan offers wireless protection, enhanced repair service as well as technology support for select smartphones, tablets and smartwatches.
S WIN GJH UZA USM TNAV UZC UZB
2018-09-14 investorplace - 4
As telcos launch the first of the 5G networks, 5G stocks will become a focus. The technology will change wireless. How much speed it will add has become a point of controversy. Estimates from a few years ago predicted the improvement at 1,000 times 4G.
BRK.A S T TMUS AAPL CSCO NOK INTC
In the past five trading days, the uptrend in telecom stocks continued driven by healthy job growth data exhibiting signs of a strengthening economy. The stocks were also fueled by optimism from a U.S. proposal to initiate talks with China in the near future to iron out the trade-related differences between the two countries. Per the U.S. Labor Department report, about 201,000 new jobs were created in August, marking the 95th straight month of employment gains in the country.
FNSR ARRS S TMUSP TMUS JNPR VZ VZA
Whenever the stock market marches higher, it pushes the prices of many companies higher along with it. But as investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend stocks for long-term investors.
LOW TXN ADP VZA HON AMT AAPL CCI CBS HON TMUSP CBS.A TMUS BDX COST CBS.WD MDT HRL S T ADPVV VZ CPV
Shares in T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) barely budged on word that regulators have “stopped the clock” on their merger. The original deal between the two, signed in April, valued Sprint stock at about $6.50 per share, but it is an all-stock transaction, about 1/10th of a T-Mobile stock share (specifically 0.10256) for each Sprint stock share.
S T TMUS VZ VZA
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to S / Sprint Corporation on message board site Silicon Investor.
as of ET